Management and Treatment of Harlequin Syndrome
Harlequin syndrome is a rare autonomic disorder that typically does not require medical treatment in most cases, with management focusing primarily on patient education and symptomatic relief for those with severe manifestations.
Understanding Harlequin Syndrome
Harlequin syndrome is characterized by:
- Unilateral facial flushing and hyperhidrosis (sweating) typically affecting the face, neck, chest, and rarely the arm
- Contralateral anhidrosis (lack of sweating)
- Symptoms triggered by exercise, heat, emotional stress, or occurring spontaneously
- Asymmetric appearance with one side of the face appearing red while the other remains pale
Etiology and Classification
Harlequin syndrome can be classified as:
- Primary (Idiopathic): No identifiable cause
- Secondary: Associated with:
- Traumatic injuries
- Tumors
- Vascular impairments of the head
- Autoimmune disorders
- Surgical complications (thoracotomy, epidural anesthesia)
Diagnostic Approach
When evaluating a patient with suspected Harlequin syndrome:
Obtain detailed history focusing on:
- Onset of symptoms (sudden vs. gradual)
- Triggering factors (exercise, heat, emotions)
- Associated symptoms (headaches, ocular symptoms)
- Previous surgeries or trauma
Physical examination should assess:
- Distribution of flushing and sweating
- Presence of associated neurological signs
- Pupillary responses
Diagnostic testing:
- MRI of brain, cervical and thoracic spine to rule out structural lesions 1
- Consider additional testing based on suspected etiology
Management Approach
1. Patient Education
- Explain the benign nature of the condition in most cases
- Reassure patients about the generally favorable prognosis
- Discuss potential triggers to avoid or manage
2. Observation and Monitoring
- For most patients with idiopathic Harlequin syndrome, observation is sufficient
- Regular follow-up to monitor for development of associated conditions
3. Pharmacological Management
For patients with severe or distressing symptoms:
- Combination therapy with oxybutynin and propranolol has shown success in managing both hyperhidrosis and facial erythema in idiopathic Harlequin syndrome 2
- Dosing should be tailored based on symptom severity and patient response
4. Surgical Interventions
For refractory cases with significant impact on quality of life:
- Sympathectomy may be considered in selected cases
- Partial T3 costotransversectomy with T2 sympathectomy has been reported to resolve symptoms 3
- Potential complications include radicular pain, which may respond to medications like gabapentin
5. Management of Secondary Harlequin Syndrome
- If related to epidural anesthesia: discontinuation or adjustment of catheter placement 4
- If associated with underlying pathology: treatment of the primary condition
Special Considerations
Pediatric Patients
- Harlequin syndrome is rare in pediatric populations
- Generally self-limiting in children
- Treatment usually unnecessary unless symptoms are incapacitating 5
Associated Conditions
- Monitor for development of associated autonomic disorders:
- Holmes-Adie syndrome
- Ross syndrome
- Ocular symptoms (present in approximately half of cases)
Prognosis
- Primary Harlequin syndrome has a favorable prognosis
- Secondary cases depend on the underlying etiology
- Most patients can be managed with reassurance and education
- Surgical intervention should be reserved for severely affected individuals with significant quality of life impairment
Caveats and Pitfalls
- Misdiagnosis: Unilateral facial flushing can be a sign of serious conditions including stroke, brain tumors, or Horner syndrome - thorough investigation is essential
- Overtreatment: Avoid unnecessary interventions for mild cases
- Underappreciation of psychological impact: The cosmetic appearance can cause significant distress requiring psychological support
- Incomplete evaluation: Failure to identify potentially treatable underlying causes
Harlequin syndrome management should focus on proper diagnosis, patient education, and targeted interventions for those with significant symptoms affecting quality of life.